Granata Bio
Granata Bio is a biotech company in Boston, United States, founded in 2021. It has raised $29.0M across 2 rounds, most recently a $15.0M Extension Round in January 2025.
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- granata.bio
- Total Funding
- $29.0M
- Last Round
- $15.0M Extension RoundJan 2025
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.
About
Granata Bio is a clinical-stage biopharmaceutical company focused on reproductive health, identifying and developing fertility treatments to expand therapeutic choices and improve access for patients. Founded in 2018 and based in Duxbury, Massachusetts, the company is advancing a pivotal Phase III study of a novel gonadotropin for assisted reproductive technology.
Summary
It lists 1–10 employees. It has raised $29.0M in total across 2 rounds, most recently a $15.0M Extension Round in Jan 2025. Investors include GV, Gedeon Richter and CooperSurgical.
Funding History
Jan 2025
Sign up to see all 2 events
Funding: Series A through Extension Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/granata-bio"><img src="https://indexed.vc/api/badge/company/granata-bio" alt="Granata Bio on Indexed.vc" width="260" height="76" /></a>